![Irlab therapeutics ab](/api/images/company-pic/0-3573009-company.png)
Contact us
About company
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the brain. IRLAB is engaged in programmes targeting core dysfunctions in Parkinson’s disease and dementias. IRLAB has identified, and is currently engaged in clinical development of, two novel compounds aimed at offering improved clinical benefit for patients with Parkinson’s disease.
SE
Unknown
Not verified company
Business transparency
- Did not verified company info
- Ask their customers for reviews
- Did not replied to negative reviews